Introduction
used with autologous CD8 cells [14] [15] [16] in other conditions HIV-1 infection leads to a gradual depletion of CD4 lymand can be proposed with CD4 cells to treat AIDS. Howphocytes, 1-3 which, irrespective of the mechanisms that ever, reinfused CD4 cells are themselves susceptible to account for this loss, 4-6 results in opportunistic infections, HIV-1 infection. [17] [18] [19] Therefore, antigen-specific human the chief cause of morbidity and mortality in AIDS. 7 In CD4 T cell lines should be made constitutively resistant contrast, opportunistic pathogens are controlled by to HIV-1, before adoptive transfer. immunocompetent individuals, as their CD4 cells react Thus, we have investigated whether antigen-specific to intracellular pathogens, 8 produce lymphokines capable CD4 cells from normal and from seropositive donors can of restraining the growth of fungi and protozoa, 9,10 and be transduced with a retroviral vector carrying an antiprovide help for clonal expansion of B cells 9 as well as of tat antisense tRNA gene 20 to be made resistant to HIV-1 CD8 cytotoxic cells.
11,12 Therefore, any treatment of AIDS replication, while maintaining their functional properties. should aim at restoring the immune repertoire that enables the patient to withstand opportunistic infections.
Immune reconstitution in AIDS patients may take
Results
advantage of adoptive immunotherapy, ie use of in vitro selected autologous CD4 T cells which recognize antigens Proliferative response of transduced T cells of opportunistic pathogens. Antigen-specific CD4 T cells
The antigen-specific lines were selected with G418 after can be isolated from HIV-1-infected individuals in the transduction. Three restimulation cycles were needed to early phases of infection 13 and can be expanded in vitro provide enough cells for functional assays (proliferation, for storage and reinfusion in patients with low CD4 cytokine and T cell receptor (TCR) V␤ profiles) and for counts that herald opportunistic infections. line ( Figure 2a ). Since more clones using the same V␤ gene can be present in a specific T cell line, 21 the number of V␤ gene families is a minimal estimate of clonal heterogeneity. Transductions were performed in parallel with the control vector and with the full vector. As shown in Figure 2a , V␤ 2, 8 and 21 were maintained in the transduced lines with overlapping profiles.
T cell lines specific for Toxoplasma antigens were also analyzed. Due to antigenic complexity of the extract, the line in Figure 2b used numerous V␤ gene families. The transduced cells, in contrast, exhibited a limited V␤ usage (V␤ 9, 6.1/4, 6H).
Spectratyping was used to analyze repertoire clonality further. In the case of the TT-specific line, single peaks corresponding to V␤ 2 and V␤ 8 were present in the bulk line. Single peaks with the same size (180 bp and 243 bp, respectively) were also detected in the transduced lines, suggesting that the same V␤ 2 and V␤ 8 clones were maintained after transduction (data not shown).
As described below, a higher transduction efficiency resulted in better preservation of repertoire heterogeneity.
Lymphokine profiles
The Toxoplasma-specific T cell line was analyzed before and after transduction for secreted IL-2 and for lymphokine gene transcripts following antigen stimulation. A Th0 type lymphokine profile, 22, 23 with production of IL-2 and mRNA specific for IL-5, IL-6, TNF␣, IFN and GM-CSF, was maintained in the transduced lines (Figure 3 ). The expression of functional markers such as CD3, CD4, CD25, CD38, CD54, CD71, p75 and DR was determined by flow cytometry. No differences were detected between the control lines and the transduced lines (data not shown).
HIV-1 challenge T lines were challenged in vitro with HIV-1 at different doses. Table 1 , upper panel, shows that the control line FM.TT was productively infected by 0.001 multiplicity of infection (MOI) and the line transduced with the control vector (FM.TT.DC) by 0.001-0.01 MOI. In contrast, 3-10 MOI was needed to infect T cells transduced with the 5 for line FM.TT.AT (Table 1) .
The genetic treatment was extended to T cell lines responding to PPD of Mycobacterium tuberculosis and to Toxoplasma-specific lines derived from normal donors was not affected by transduction. G418 sensitivity of the Toxoplasma, since these pathogens are relevant for opportunistic infections in AIDS. When the PPD specific control cells was evident in a 5-day proliferation assay. G418 exhibited negligible or limited inhibitory effect on control line (AK.PPD) and the transduced counterpart (AK.PPD.AT) were challenged with HIV-1, 0.01 MOI and the resistant cells. The proliferative potential of transduced cells compares with that of control cells. In fact, 1 MOI were required, respectively, to produce a syncytium-forming virus in the supernatants (Table 1) . Detectthey can be expanded to large numbers according to protocols already used for CD8 cells.
14 able viral antigen p24 (10 pg/ml) was found in the supernatants of the same T cell lines infected with 0.001 and with 0.2 MOI, respectively (Table 1) . Protection factors Repertoire skewing Transduction efficiency estimated in several experiments (ratio between infectious dose for transduced and for control cells) are also shown in parentheses. ranged from 0.1 to 0.5%. To evaluate the clonal composition of antigen-specific lines we analyzed the TCR V␤ Experiments were performed to compare resistance with the HXB2 and the SF2 strains. Protection factors as gene usage before and after transduction.
Several V␤ gene families were used by the TT-specific high as 10 000 in the syncytium assay and 5000 in the p24 
Figure 3 Lymphokine production. The DB.Toxo T cell lines were analyzed for IL-2 secretion and for transcription of other lymphokine genes. The Th0 type of lymphokine profile was maintained after transduction with the control vector (DC) and with the antisense vectors (AT).
assay were also seen with the SF2 strain (Table 1, lower efficiency. As shown in Figure 4 , proliferative activity of panel). Therefore, the therapeutic gene is effective against T cell lines from patient RM was intact after transduction, two strains of HIV-1 that are divergent at the level of the even in the presence of G418. target tat sequence (nucleotides 5933-5952), with misThe increased transduction efficiency achieved with matches at nucleotides 5942, 5944, 5946 and 5947. 24 the CA-specific line resulted in preservation of multiclonThe lines challenged and resistant to 1 MOI in experiality. As shown in Figure 5 , in fact, all V␤ gene families ment 1 were restimulated with antigen and IL-2, exhibitused by the control line were expressed in the transduced ing a normal proliferative response. No infectious virus line. V␤ gene families 2, 8 and 21 were also analyzed for was detected in the supernatant (data not shown). The clonal heterogeneity by spectratyping. Single peaks were lines were re-challenged with the same HIV-1 dose and detected within each family, and single peaks with the resistance was confirmed (data not shown).
same nucleotide length were observed in the transduced cells, suggesting that the same clones were preserved Transduction of specific T cell lines from a seropositive (data not shown). donor Table 2 shows that in the absence of AZT the trans-CD4 T cell lines were generated from the seropositive duced T cell line no longer replicates infectious virus, as asymptomatic donor RM by stimulation with PPD and opposed to the control line (no viral challenge, 0 MOI) with CA in the presence of AZT at 1 g/ml. AZT was that produces low levels of infectious virus detected by required to maintain normal expansion of T cells from the syncytium assay, but not by the p24 assay. The constithe patient upon repeated stimulation cycles. In the tutively HIV-1 replicating control line produced more absence of AZT, in fact, cell yield decreased by a factor viral antigen with increasing challenge doses, with a of 5, with detectable infectious virus in the supernatant.
positive p24 level at 0.01 MOI. In contrast, when the This suggests that a fraction of the antigen-specific T cells transduced line was challenged, 10 MOI was required for is infected and that HIV can spread to antigen-activated a productive infection according to the syncytium assay, CD4 blasts in the absence of AZT, with increased virus and 1 MOI was needed to induce detectable p24. production to detectable levels.
The inability of transduced cells to replicate HIV was The PPD-and CA-specific lines were transduced with not related to loss of integrated provirus. Viral DNA was the modified protocol described in the Materials and in fact maintained in the transduced cells, as shown in methods, that uses a higher concentration and an Figure 6 . extended exposure to the vector, resulting in 6% the naive lymphocytes derived from staminal precursors. Antigen nonspecific lymphocytes may be of limited use, because only a minor fraction of the cells is specific for opportunistic pathogens, the majority of the T cells being Discussion specific for irrelevant antigens. Moreover, preservation of the functional properties of these cells after transduction Immunodeficiency associated with AIDS is characterized by the loss of CD4 lymphocytes specific for opportunistic has not been documented. Four major points emerge from this study. First, transpathogens. Therefore, reconstitution of the immune repertoire with such cells is an attractive option. However, duction is responsible for repertoire skewing when efficiency is low (0.1-0.5%), but not when efficiency is immune reconstitution may be ineffective if the reinfused cells are themselves susceptible to HIV-1 infection.
increased (6%). Second, antigen-specific T cells are not affected by transduction in their biological functions, Here, we have shown that antigen-specific CD4 lymphocytes, when genetically treated with an anti-HIV-1 tat including proliferative response to antigen, transcription of lymphokine genes and surface phenotypic markers; gene, require a 100-10 000-fold higher HIV-1 challenge to replicate infectious virus, as compared with controls. To thus, interaction with antigen presenting cells, homing to inflammatory sites and proliferation in vivo are likely preour knowledge, this is the first demonstration that antigen-specific human CD4 lymphocytes can be made resistserved. Third, antigen-specific T cells that constitutively express the anti-HIV-1 gene require up to 10 000-fold ant to HIV-1 replication while maintaining their functional properties.
higher input MOI to produce infectious virus, as compared with control cells. Fourth, antigen-specific CD4 T To date, a number of strategies have been proposed to adopt gene therapy in HIV-1 infection 25, 26 using maligcells infected by HIV-1 in vivo no longer replicate infectious virus after genetic treatment, even though the pronant T cell lines, 20,27-30 CD34 stem cells 31 or antigen nonspecific lymphocytes [32] [33] [34] [35] [36] [37] [38] as targets. Malignant T cells can viral DNA is retained. This strategy can be refined, since the protective mechonly be used as in vitro models, but have no in vivo applications. HIV-1-resistant CD34 stem cells can, in principle, anism we exploited prevents tat-driven transcription, but does not affect integration. Interference with both be used to reconstitute the precursor pool from which 
The control (RM.CA) and the transduced (RM.CA.AT) CA-specific lines were tested for virus replication with the syncytium formation assay and with the p24 assay. A positive syncytium assay is defined in Materials and methods. p24 Concentration is shown as pg/ml, with a detection limit of 5 pg/ml. The RM.CA control line spontaneously produced infectious virus detected by the syncytium assay (but not by the p24 assay) in the absence of challenge (0 MOI), in contrast to the RM.CA.AT transduced line that required superinfection to become productive. When challenged with increasing HIV-1 doses, the control line exhibited a positive p24 assay (Ͼ10 pg/ml) at 0.01 MOI, while 1 MOI was needed to detect p24 and infectious virus in the supernatant of the transduced line.
integration and replication may be achieved by combinreinfused cells, as highlighted with CD8 cells encoding the HSV thymidine kinase and the hygromycin phosphoing the expression of tat antisense with a ribozyme that degrades genomic RNA. 41 A further improvement contransferase genes. 44 If transduction efficiency is increased, the selection marker can be omitted from the vector, and cerns the substitution of the neo gene in the vector backbone with a non-antigenic selection marker. 42, 43 Neothe cells could be used without in vitro selection.
Genetic treatment of CD4
+ lymphocytes from specific CTL could in fact be induced in vivo and kill the HIV-1-resistant antigen-specific CD4 lymphocytes F Manca et al 1222
Materials and methods
Media and antigens RPMI 1640 (Flow, Irvine, UK) supplemented with l-glutamine, antibiotics, 2-mercaptoethanol and 5% human AB serum (Blood Bank, Gaslini Institute, Genoa, Italy), was used for in vitro cultures. 51 Human recombinant interleukin 2 (IL-2, Proleukin) was donated by Chiron Italy, Milan, Italy. PPD was purchased from Statens Seruminstitut, Copenhagen, Denmark, and Tetanus toxoid (TT) from Connaught Laboratories, London, Canada. Toxoplasma gondii extract, prepared by sonication of detergenttreated bodies, was provided by Bouty Laboratories, Milan, Italy. Candida albicans (CA) bodies grown in RPMI 1640 medium were washed and autoclaved before use in culture.
Antigen-specific T cell lines
The generation of T cell lines has been described in detail. [51] [52] [53] Briefly, peripheral blood mononuclear cells (PBMC) were obtained from heparinized venous blood separated on a Ficoll gradient. PBMC were resuspended at 10 × 10 6 /ml in complete medium and pulsed with antigens for 4 h at 37°C. TT was used at 5 g/ml, PPD at 10 2 × 10 5 T cells were restimulated with 5 × 10 5 fresh autologous, antigen pulsed, 3000 rads irradiated ( 137 Cs source, Gammacell, Atomic Energy of Canada) PBMC plus 30 U/ml IL-2. The cultures were split 1:4 when cell density was Ͼ10 6 /ml. Restimulation cycles were repeated every patients 32, 35 should ideally focus on HIV-1-negative cells, 3 weeks. These culture conditions select for CD4 cells. but this possibility is more likely in early infection. On CD4 + , WT31 + (␣␤ TCR + ) cells account for Ͼ95% of T cells the other hand, genetic treatment of HIV-1-positive CD4 after two stimulation cycles. No CD8 cells were detected cells, by silencing virus replication, is feasible, as shown in these lines after four stimulation cycles. The specific T here with a primary isolate. This could prevent recogcell line from the asymptomatic seropositive donor RM nition of infected cells by HIV-1-specific CTL, thereby (CDC category A1, 510 CD4 cells/l, AZT and ddC treatremoving one of the mechanisms contributing to CD4 ment for 2 months when T cell lines were started) was depletion.
6 Consequently genetic treatment of infected established in the presence of 1 g/ml AZT. Proliferative CD4 cells in advanced AIDS could still be an effective response was tested on 10 4 T cells in the presence of 10 5 procedure, especially if combined with an antiviral regiautologous irradiated PBMC seeded in 0.2 ml medium in men that has the potential of reducing the viral load. TCR gene analysis by PCR was performed with a panel cell blasts. 38, 41 Therefore, the two approaches could of V␤-specific primers. 54-56 PCR products, separated on synergize with protease inhibitors and with reverse tranan agarose gel, were quantified by videodensitometry scriptase inhibitors, respectively, that reduce viral load with a Collage version 3.0 software (FotoDyne, Hartland, and promote rise of CD4 counts. 48, 49 WI, USA). Spectratyping 57,58 was performed to define Normal autologous lymphocytes grow only in the clonal heterogeneity of antigen-specific T cells using one presence of antigen and antigen presenting cells (APC),
given V␤ gene family as described in detail. 
